Voya Investment Management LLC Prometheus Biosciences, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$103.46 - $126.29 $5.36 Million - $6.54 Million	51,761 Added 73.17%	122,504 $13.1 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $672,807 - $2.19 Million	18,658 Added 35.82%	70,743 $7.78 Million
Q3 2022 Mar 03, 2023	SELL	$28.17 - $59.01 $525,595 - $1.1 Million	-18,658 Reduced 26.37%	52,085 $3.07 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $1.15 Million - $2.4 Million	40,731 Added 358.74%	52,085 $3.07 Million
Q2 2022 Aug 15, 2022	SELL	$22.39 - $38.94 $9,090 - $15,809	-406 Reduced 3.45%	11,354 $321,000
Q1 2022 May 16, 2022	BUY	$30.13 - $50.0 $26,062 - $43,250	865 Added 7.94%	11,760 $444,000
Q4 2021 Feb 14, 2022	BUY	$22.28 - $39.54 $242,740 - $430,788	10,895 New	10,895 $431,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.